Advanced Search
DSpace@MIT

Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome

Research and Teaching Output of the MIT Community

Files in this item

Name Size Format
Downloadable Full Text - PDF

This item appears in the following Collection(s)

Open Access